SlideShare une entreprise Scribd logo
1  sur  6
Diagnosis of Pancreatic Cancer with EUS-FNA:   Factors That Influence  Adequate Sampling
Ali Lankarani, MD 3rd year GI fellow Allegheny General Hospital / Drexel University Pittsburgh Manish K. Dhawan, MD Disclaimer: Not an endosonographer
Pancreatic Cancer ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]
Identifying the factors that may influence the number of FNA passes: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Endosonographer’s  experience Location of the tumor Size of pancreatic mass 2.5 3.0 2.4 2.4 3.1 2.4 Ave # of Passes 51-70 mm (n=8) 41-50 mm (n=13) 31-40 mm (n=55) 21-30 mm (n=62) 11-20 mm (n=24) <10 mm (n=5) Mass size

Contenu connexe

Tendances

Older Adult Survivorship
Older Adult SurvivorshipOlder Adult Survivorship
Older Adult SurvivorshipOSUCCC - James
 
State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...
State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...
State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...Health Sciences North | Horizon Santé Nord
 
Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...
Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...
Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...Health Sciences North | Horizon Santé Nord
 
'Living Well' Conference 2013: The National Context of Survivorship
'Living Well' Conference 2013: The National Context of Survivorship'Living Well' Conference 2013: The National Context of Survivorship
'Living Well' Conference 2013: The National Context of SurvivorshipPennyBrohnComms
 
New Trends in the Management of Metastatic Prostate Cancer
New Trends in the Management of Metastatic Prostate CancerNew Trends in the Management of Metastatic Prostate Cancer
New Trends in the Management of Metastatic Prostate Cancerflasco_org
 
Cancer in Adolescents and Young Adults
Cancer in Adolescents and Young AdultsCancer in Adolescents and Young Adults
Cancer in Adolescents and Young AdultsDr.T.Sujit :-)
 
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...Emad Shash
 
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...bkling
 
Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO Chief, Department of S...
Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO  Chief, Department of S...Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO  Chief, Department of S...
Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO Chief, Department of S...Cancer Treatment Centers of America
 
5th Annual Early Age Onset Colorectal Cancer Summit - Session IV
5th Annual Early Age Onset Colorectal Cancer Summit - Session IV5th Annual Early Age Onset Colorectal Cancer Summit - Session IV
5th Annual Early Age Onset Colorectal Cancer Summit - Session IVColon Cancer Challenge Foundation
 
Prognosis and Medical Oncology Follow-up of Uveal Melanoma
Prognosis and Medical Oncology Follow-up of Uveal MelanomaPrognosis and Medical Oncology Follow-up of Uveal Melanoma
Prognosis and Medical Oncology Follow-up of Uveal MelanomaMelanoma Research Foundation
 
Poster for CAP final
Poster for CAP finalPoster for CAP final
Poster for CAP finalRyan Glass
 
Multidisciplinarity and the Prostate Cancer Unit
Multidisciplinarity and the Prostate Cancer UnitMultidisciplinarity and the Prostate Cancer Unit
Multidisciplinarity and the Prostate Cancer UnitEuropa Uomo EPAD
 
Epidemiology of Prostate Cancer in Puerto Rico
Epidemiology of Prostate Cancer in Puerto Rico Epidemiology of Prostate Cancer in Puerto Rico
Epidemiology of Prostate Cancer in Puerto Rico flasco_org
 
SHARE Presentation: New Developments in the Medical Treatment of Breast Cance...
SHARE Presentation: New Developments in the Medical Treatment of Breast Cance...SHARE Presentation: New Developments in the Medical Treatment of Breast Cance...
SHARE Presentation: New Developments in the Medical Treatment of Breast Cance...bkling
 

Tendances (20)

Older Adult Survivorship
Older Adult SurvivorshipOlder Adult Survivorship
Older Adult Survivorship
 
State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...
State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...
State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...
 
Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...
Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...
Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...
 
'Living Well' Conference 2013: The National Context of Survivorship
'Living Well' Conference 2013: The National Context of Survivorship'Living Well' Conference 2013: The National Context of Survivorship
'Living Well' Conference 2013: The National Context of Survivorship
 
Wiseman opac2013
Wiseman opac2013Wiseman opac2013
Wiseman opac2013
 
New Trends in the Management of Metastatic Prostate Cancer
New Trends in the Management of Metastatic Prostate CancerNew Trends in the Management of Metastatic Prostate Cancer
New Trends in the Management of Metastatic Prostate Cancer
 
Cancer in Adolescents and Young Adults
Cancer in Adolescents and Young AdultsCancer in Adolescents and Young Adults
Cancer in Adolescents and Young Adults
 
Screening cáncer próstata, nejm, marzo 2017
Screening cáncer próstata, nejm, marzo 2017Screening cáncer próstata, nejm, marzo 2017
Screening cáncer próstata, nejm, marzo 2017
 
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
 
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
 
Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO Chief, Department of S...
Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO  Chief, Department of S...Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO  Chief, Department of S...
Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO Chief, Department of S...
 
5th Annual Early Age Onset Colorectal Cancer Summit - Session IV
5th Annual Early Age Onset Colorectal Cancer Summit - Session IV5th Annual Early Age Onset Colorectal Cancer Summit - Session IV
5th Annual Early Age Onset Colorectal Cancer Summit - Session IV
 
Prognosis and Medical Oncology Follow-up of Uveal Melanoma
Prognosis and Medical Oncology Follow-up of Uveal MelanomaPrognosis and Medical Oncology Follow-up of Uveal Melanoma
Prognosis and Medical Oncology Follow-up of Uveal Melanoma
 
Poster for CAP final
Poster for CAP finalPoster for CAP final
Poster for CAP final
 
Multidisciplinarity and the Prostate Cancer Unit
Multidisciplinarity and the Prostate Cancer UnitMultidisciplinarity and the Prostate Cancer Unit
Multidisciplinarity and the Prostate Cancer Unit
 
Epidemiology of Prostate Cancer in Puerto Rico
Epidemiology of Prostate Cancer in Puerto Rico Epidemiology of Prostate Cancer in Puerto Rico
Epidemiology of Prostate Cancer in Puerto Rico
 
35_FERRIOL.pptx
35_FERRIOL.pptx35_FERRIOL.pptx
35_FERRIOL.pptx
 
Research Day Poster
Research Day PosterResearch Day Poster
Research Day Poster
 
EPAD 2017 Ian Banks
EPAD 2017 Ian BanksEPAD 2017 Ian Banks
EPAD 2017 Ian Banks
 
SHARE Presentation: New Developments in the Medical Treatment of Breast Cance...
SHARE Presentation: New Developments in the Medical Treatment of Breast Cance...SHARE Presentation: New Developments in the Medical Treatment of Breast Cance...
SHARE Presentation: New Developments in the Medical Treatment of Breast Cance...
 

Similaire à Cairo presentation final with voice and time

Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on ...
Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on ...Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on ...
Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on ...alessandrolealmd
 
Update on Cervical Cancer Screening Barb Apgar.ppt
Update on Cervical Cancer Screening Barb Apgar.pptUpdate on Cervical Cancer Screening Barb Apgar.ppt
Update on Cervical Cancer Screening Barb Apgar.pptSyedaAyeshaFatima2
 
ADR-NEJM-Study-Article-PVMD.pdf
ADR-NEJM-Study-Article-PVMD.pdfADR-NEJM-Study-Article-PVMD.pdf
ADR-NEJM-Study-Article-PVMD.pdfKevinChang954136
 
Endoscopy in Gastrointestinal Oncology - Slide 15 - D. Fisher - Colorectal ca...
Endoscopy in Gastrointestinal Oncology - Slide 15 - D. Fisher - Colorectal ca...Endoscopy in Gastrointestinal Oncology - Slide 15 - D. Fisher - Colorectal ca...
Endoscopy in Gastrointestinal Oncology - Slide 15 - D. Fisher - Colorectal ca...European School of Oncology
 
Pathology and How to Understand It
Pathology and How to Understand ItPathology and How to Understand It
Pathology and How to Understand Itflasco_org
 
Psa guideline exercise
Psa guideline exercisePsa guideline exercise
Psa guideline exerciseJohn Voss
 
Mon 8-00 Prostate Cancer Screening in the Post-USPSTF Era_0.pptx
Mon 8-00   Prostate Cancer Screening in the Post-USPSTF Era_0.pptxMon 8-00   Prostate Cancer Screening in the Post-USPSTF Era_0.pptx
Mon 8-00 Prostate Cancer Screening in the Post-USPSTF Era_0.pptxRonitEnterprises
 
RESEARCH & TREATMENT NEWS: Highlights from the 2014 GI Cancer Symposium
RESEARCH & TREATMENT NEWS:  Highlights from the 2014 GI Cancer SymposiumRESEARCH & TREATMENT NEWS:  Highlights from the 2014 GI Cancer Symposium
RESEARCH & TREATMENT NEWS: Highlights from the 2014 GI Cancer SymposiumFight Colorectal Cancer
 
Screening for Prostate Cancer NEJM cases 2012
Screening for Prostate Cancer NEJM cases 2012Screening for Prostate Cancer NEJM cases 2012
Screening for Prostate Cancer NEJM cases 2012Aieme Uam
 
Breast Cancer Screening
Breast Cancer ScreeningBreast Cancer Screening
Breast Cancer ScreeningAsha Reddy
 
3 minute talk July 2014 [Autosaved]
3 minute talk July 2014 [Autosaved]3 minute talk July 2014 [Autosaved]
3 minute talk July 2014 [Autosaved]Jaeda Patton
 
factores de riesgo DM2
factores de riesgo DM2factores de riesgo DM2
factores de riesgo DM2MelendiNavarro
 
Screening for carcinoma prostate
Screening for carcinoma prostateScreening for carcinoma prostate
Screening for carcinoma prostatePrakash Hs
 
Screening in Asbestos-related diseases (lung cancer) at Helsinki Asbestos 2014
Screening in Asbestos-related diseases (lung cancer) at Helsinki Asbestos 2014Screening in Asbestos-related diseases (lung cancer) at Helsinki Asbestos 2014
Screening in Asbestos-related diseases (lung cancer) at Helsinki Asbestos 2014Työterveyslaitos
 
Familial predisposition for colorectal cancers: Who to screen?
Familial predisposition for colorectal cancers: Who to screen?Familial predisposition for colorectal cancers: Who to screen?
Familial predisposition for colorectal cancers: Who to screen?OSUCCC - James
 
Kiow 11 2017 metastatic colon cancer from bench to clinic
Kiow 11 2017 metastatic colon cancer from bench to clinicKiow 11 2017 metastatic colon cancer from bench to clinic
Kiow 11 2017 metastatic colon cancer from bench to clinicMohamed Abdulla
 
Week 6 DiscussionQuestion ARisk management is a matter of id.docx
Week 6 DiscussionQuestion ARisk management is a matter of id.docxWeek 6 DiscussionQuestion ARisk management is a matter of id.docx
Week 6 DiscussionQuestion ARisk management is a matter of id.docxcockekeshia
 
Il carcinoma della prostata nel terzo millennio
Il carcinoma della prostata nel terzo millennioIl carcinoma della prostata nel terzo millennio
Il carcinoma della prostata nel terzo millenniodott. Comeri Giancarlo
 

Similaire à Cairo presentation final with voice and time (20)

Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on ...
Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on ...Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on ...
Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on ...
 
Update on Cervical Cancer Screening Barb Apgar.ppt
Update on Cervical Cancer Screening Barb Apgar.pptUpdate on Cervical Cancer Screening Barb Apgar.ppt
Update on Cervical Cancer Screening Barb Apgar.ppt
 
ADR-NEJM-Study-Article-PVMD.pdf
ADR-NEJM-Study-Article-PVMD.pdfADR-NEJM-Study-Article-PVMD.pdf
ADR-NEJM-Study-Article-PVMD.pdf
 
Endoscopy in Gastrointestinal Oncology - Slide 15 - D. Fisher - Colorectal ca...
Endoscopy in Gastrointestinal Oncology - Slide 15 - D. Fisher - Colorectal ca...Endoscopy in Gastrointestinal Oncology - Slide 15 - D. Fisher - Colorectal ca...
Endoscopy in Gastrointestinal Oncology - Slide 15 - D. Fisher - Colorectal ca...
 
Pathology and How to Understand It
Pathology and How to Understand ItPathology and How to Understand It
Pathology and How to Understand It
 
Psa guideline exercise
Psa guideline exercisePsa guideline exercise
Psa guideline exercise
 
Mon 8-00 Prostate Cancer Screening in the Post-USPSTF Era_0.pptx
Mon 8-00   Prostate Cancer Screening in the Post-USPSTF Era_0.pptxMon 8-00   Prostate Cancer Screening in the Post-USPSTF Era_0.pptx
Mon 8-00 Prostate Cancer Screening in the Post-USPSTF Era_0.pptx
 
RESEARCH & TREATMENT NEWS: Highlights from the 2014 GI Cancer Symposium
RESEARCH & TREATMENT NEWS:  Highlights from the 2014 GI Cancer SymposiumRESEARCH & TREATMENT NEWS:  Highlights from the 2014 GI Cancer Symposium
RESEARCH & TREATMENT NEWS: Highlights from the 2014 GI Cancer Symposium
 
Oncotype dx
Oncotype dxOncotype dx
Oncotype dx
 
Screening for Prostate Cancer NEJM cases 2012
Screening for Prostate Cancer NEJM cases 2012Screening for Prostate Cancer NEJM cases 2012
Screening for Prostate Cancer NEJM cases 2012
 
Breast Cancer Screening
Breast Cancer ScreeningBreast Cancer Screening
Breast Cancer Screening
 
3 minute talk July 2014 [Autosaved]
3 minute talk July 2014 [Autosaved]3 minute talk July 2014 [Autosaved]
3 minute talk July 2014 [Autosaved]
 
factores de riesgo DM2
factores de riesgo DM2factores de riesgo DM2
factores de riesgo DM2
 
Screening for carcinoma prostate
Screening for carcinoma prostateScreening for carcinoma prostate
Screening for carcinoma prostate
 
Screening in Asbestos-related diseases (lung cancer) at Helsinki Asbestos 2014
Screening in Asbestos-related diseases (lung cancer) at Helsinki Asbestos 2014Screening in Asbestos-related diseases (lung cancer) at Helsinki Asbestos 2014
Screening in Asbestos-related diseases (lung cancer) at Helsinki Asbestos 2014
 
Familial predisposition for colorectal cancers: Who to screen?
Familial predisposition for colorectal cancers: Who to screen?Familial predisposition for colorectal cancers: Who to screen?
Familial predisposition for colorectal cancers: Who to screen?
 
Kiow 11 2017 metastatic colon cancer from bench to clinic
Kiow 11 2017 metastatic colon cancer from bench to clinicKiow 11 2017 metastatic colon cancer from bench to clinic
Kiow 11 2017 metastatic colon cancer from bench to clinic
 
Week 6 DiscussionQuestion ARisk management is a matter of id.docx
Week 6 DiscussionQuestion ARisk management is a matter of id.docxWeek 6 DiscussionQuestion ARisk management is a matter of id.docx
Week 6 DiscussionQuestion ARisk management is a matter of id.docx
 
Il carcinoma della prostata nel terzo millennio
Il carcinoma della prostata nel terzo millennioIl carcinoma della prostata nel terzo millennio
Il carcinoma della prostata nel terzo millennio
 
Cancer screening
Cancer screeningCancer screening
Cancer screening
 

Cairo presentation final with voice and time

  • 1. Diagnosis of Pancreatic Cancer with EUS-FNA: Factors That Influence Adequate Sampling
  • 2. Ali Lankarani, MD 3rd year GI fellow Allegheny General Hospital / Drexel University Pittsburgh Manish K. Dhawan, MD Disclaimer: Not an endosonographer
  • 3.
  • 4.
  • 5.
  • 6. Endosonographer’s experience Location of the tumor Size of pancreatic mass 2.5 3.0 2.4 2.4 3.1 2.4 Ave # of Passes 51-70 mm (n=8) 41-50 mm (n=13) 31-40 mm (n=55) 21-30 mm (n=62) 11-20 mm (n=24) <10 mm (n=5) Mass size